The study offers a valuable resource and integrates multiple complementary datasets to provide insights into regulatory mechanisms, although the conceptual advances are moderate and the central ...
A novel low-cost assay sequencing cell-free DNA methylome in blood demonstrates strong performance across a range of clinical applications.
Responding to reports from peer reviewers is a crucial part of scientific publishing, but early-career researchers are rarely taught about this process.
Expands potential opportunities for AKTX-101 and its novel RNA splicing modulator payload in additional tumors beyond current ...
Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...
Former FBI special agent Jennifer Coffindaffer has said the family of missing Arizona grandmother Nancy Guthrie, including ...
GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
Some smaller crystals were never recovered at all. The findings, published March 3, 2026 in the journal Frontiers in ...
Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University Hospital (UKHD) using a TCR T-cell therapy engineered with a PRAME-directed TCR ...
Ancient DNA reveals how farming accelerated human evolution, driving genetic changes over the past 10,000 years.
The idea that modern humans inherited DNA from Neanderthal ancestors is one of the 21st century’s most celebrated discoveries ...
Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results